Drug Name: Vtama
Active Ingredient: tapinarof
Indications: To treat plaque psoriasis
Approval Date: 5/23/2022
Company: Dermavant Sciences Inc, Dermavant Sciences, GmbH
Learn more: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215272s000lbl.pdf